The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Artificial Intelligence for COVID-19: A Systematic Review
Open accessAbstract
Background: Recently, Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome virus 2 (SARS-CoV-2), has affected more than 200 countries and lead to enormous losses. This study systematically reviews the application of Artificial Intelligence (AI) techniques in COVID-19, especially for diagnosis, estimation of epidemic trends, prognosis, and exploration of effective and safe drugs and vaccines; and discusses the potential limitations. Methods: We report this systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched PubMed, Embase and the Cochrane Library from inception to 19 September 2020 for published studies of AI applications in COVID-19. We used PROBAST (prediction model risk of bias assessment tool) to assess the quality of literature related to the diagnosis and prognosis of COVID-19. We registered the protocol (PROSPERO CRD42020211555). Results: We included 78 studies: 46 articles discussed AI-assisted diagnosis for COVID-19 with total accuracy of 70.00 to 99.92%, sensitivity of 73.00 to 100.00%, specificity of 25 to 100.00%, and area under the curve of 0.732 to 1.000. Fourteen articles evaluated prognosis based on clinical characteristics at hospital admission, such as clinical, laboratory and radiological characteristics, reaching accuracy of 74.4 to 95.20%, sensitivity of 72.8 to 98.00%, specificity of 55 to 96.87% and AUC of 0.66 to 0.997 in predicting critical COVID-19. Nine articles used AI models to predict the epidemic of the COVID-19, such as epidemic peak, infection rate, number of infected cases, transmission laws, and development trend. Eight articles used AI to explore potential effective drugs, primarily through drug repurposing and drug development. Finally, 1 article predicted vaccine targets that have the potential to develop COVID-19 vaccines. Conclusions: In this review, we have shown that AI achieved high performance in diagnosis, prognosis evaluation, epidemic prediction and drug discovery for COVID-19. AI has the potential to enhance significantly existing medical and healthcare system efficiency during the COVID-19 pandemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020) · JAMA · doi:10.1001/jama.2020.12839 · Cited by 4,609
The potential for artificial intelligence in healthcare
Davenport, T., & Kalakota, R. (2019) · Future Healthcare Journal · doi:10.7861/futurehosp.6-2-94 · Cited by 3,800
PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies
Wolff, R. F., Moons, K. G. M., Riley, R. D., Whiting, P. F., Westwood, M., Collins, G. S., Reitsma, J. B., Kleijnen, J., Mallett, S., & for the PROBAST Group† (2019) · Annals of Internal Medicine · doi:10.7326/m18-1376 · Cited by 2,984
Apostolopoulos, I. D., & Mpesiana, T. A. (2020) · Physical and Engineering Sciences in Medicine · doi:10.1007/s13246-020-00865-4 · Cited by 2,338
Li, L., Qin, L., Xu, Z., Yin, Y., Wang, X., Kong, B., Bai, J., Lu, Y., Fang, Z., Song, Q., et al. (2020) · Radiology · doi:10.1148/radiol.2020200905 · Cited by 1,927
Self-citationMoons, K. G. M., Wolff, R. F., Riley, R. D., Whiting, P. F., Westwood, M., Collins, G. S., Reitsma, J. B., Kleijnen, J., & Mallett, S. (2019) · Annals of Internal Medicine · doi:10.7326/m18-1377 · Cited by 1,669
A Deep Learning System to Screen Novel Coronavirus Disease 2019 Pneumonia
Xu, X., Jiang, X., Ma, C., Du, P., Li, X., Lv, S., Yu, L., Ni, Q., Chen, Y., Su, J., et al. (2020) · Engineering · doi:10.1016/j.eng.2020.04.010 · Cited by 1,209
Artificial intelligence–enabled rapid diagnosis of patients with COVID-19
Mei, X., Lee, H.-C., Diao, K.-Y., Huang, M., Lin, B., Liu, C., Xie, Z., Ma, Y., Robson, P. M., Chung, M., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0931-3 · Cited by 1,084
Zhang, K., Liu, X., Shen, J., Li, Z., Sang, Y., Wu, X., Zha, Y., Liang, W., Wang, C., Wang, K., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.045 · Cited by 917
Self-citationArtificial intelligence in medical practice: the question to the answer?
Miller, D. D., & Brown, E. W. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.10.035 · Cited by 774
Rahimzadeh, M., & Attar, A. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100360 · Cited by 695
Machine Learning and Health Care Disparities in Dermatology
Adamson, A. S., & Smith, A. (2018) · JAMA Dermatology · doi:10.1001/jamadermatol.2018.2348 · Cited by 639 · cited 1×
“Artificial intelligence (AI) is a field of algorithm-based applications that enable machines to solve knowledge problems and use algorithms to simulate human decision-making, and continuously improves performance by applying inputted data to perform specific tasks (9–11).”
BackgroundExplainable Deep Learning for Pulmonary Disease and Coronavirus COVID-19 Detection from X-rays
Brunese, L., Mercaldo, F., Reginelli, A., & Santone, A. (2020) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2020.105608 · Cited by 623
Harmon, S. A., Sanford, T. H., Xu, S., Turkbey, E. B., Roth, H., Xu, Z., Yang, D., Myronenko, A., Anderson, V., Amalou, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17971-2 · Cited by 587
Mahmud, T., Rahman, M. A., & Fattah, S. A. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.103869 · Cited by 525
COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning
Ong, E., Wong, M. U., Huffman, A., & He, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01581 · Cited by 499
Kim, D. W., Jang, H. Y., Kim, K. W., Shin, Y., & Park, S. H. (2019) · Korean Journal of Radiology · doi:10.3348/kjr.2019.0025 · Cited by 459 · cited 1×
“This may cause the problem of overfitting of the models (108, 109).”
BackgroundBai, H. X., Wang, R., Xiong, Z., Hsieh, B., Chang, K., Halsey, K., Tran, T. M. L., Choi, J. W., Wang, D.-C., Shi, L.-B., et al. (2020) · Radiology · doi:10.1148/radiol.2020201491 · Cited by 381
Self-citationDeep learning with convolutional neural network in radiology
Yasaka, K., Akai, H., Kunimatsu, A., Kiryu, S., & Abe, O. (2018) · Japanese Journal of Radiology · doi:10.1007/s11604-018-0726-3 · Cited by 368 · cited 1×
“Deep learning with a convolutional neural network (CNN) has gained increasing attention for its outstanding image recognition performance (98).”
BackgroundArtificial intelligence vs COVID-19: limitations, constraints and pitfalls
Naudé, W. (2020) · AI & SOCIETY · doi:10.1007/s00146-020-00978-0 · Cited by 368
Toraman, S., Alakus, T. B., & Turkoglu, I. (2020) · Chaos, Solitons & Fractals · doi:10.1016/j.chaos.2020.110122 · Cited by 327
Nour, M., Cömert, Z., & Polat, K. (2020) · Applied Soft Computing · doi:10.1016/j.asoc.2020.106580 · Cited by 316
Mushtaq, J., Pennella, R., Lavalle, S., Colarieti, A., Steidler, S., Martinenghi, C. M. A., Palumbo, D., Esposito, A., Rovere-Querini, P., Tresoldi, M., et al. (2021) · European Radiology · doi:10.1007/s00330-020-07269-8 · Cited by 124
Cited by
Khogali, H. O., & Mekid, S. (2023) · Technology in Society · doi:10.1016/j.techsoc.2023.102232 · Cited by 335
Using artificial intelligence to improve public health: a narrative review
Olawade, D. B., Wada, O. J., David-Olawade, A. C., Kunonga, E., Abaire, O., & Ling, J. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1196397 · Cited by 274
Towards evidence-based practice 2.0: leveraging artificial intelligence in healthcare
Nilsen, P., Sundemo, D., Heintz, F., Neher, M., Nygren, J., Svedberg, P., & Petersson, L. (2024) · Frontiers in Health Services · doi:10.3389/frhs.2024.1368030 · Cited by 39
A Field Test of Popular Chatbots’ Responses To Questions Concerning Negative Body Image
An, R., Byron, C. W., Chen, C., & Xiang, X. (2023) · Health Behavior Research · doi:10.4148/2572-1836.1164 · Cited by 6
Metadata
- Authors
- Wang, L., Zhang, Y., Wang, D., Tong, X., Liu, T., Zhang, S., Huang, J., Zhang, L., Chen, L., Fan, H., & Clarke, M.
- Venue
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Published
- 2021-09-30
- Volume
- 8
- Pages
- 704256-704256
- ISSN
- 2296-858X (ISSN-L)
- OpenAlex
- W3204794075
- Cited by
- 182
- References
- 24
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.